Skip to main content
. 2015 Mar 17;10(3):e0119832. doi: 10.1371/journal.pone.0119832

Fig 4. Efficacy of AUY922 in HCC827/GR and HCC827/ER tumor xenograft models.

Fig 4

A, SCID mice with established HCC827/GR and HCC827/ER tumor cell xenografts were treated with AUY922. Tumor size was measured on the indicated days, and tumor volume was calculated. Arrows mean last day of drug treatment (red arrow, HCC827/GR; purple arrow, HCC827/ER). Bars represent the mean tumor volume ± SD. B and C, Immunohistochemical staining for Ki-67 and TUNEL followed by quantitative analysis of proliferation and apoptosis in (B) Ki-67+ cells and (C) TUNEL+ cells. *p< 0.01 and **p< 0.001 in comparison with the control.